NCT04451967 is a clinical trial of thrombolysis in Acute Myocardial Infarction, sponsored by Second Hospital of Jilin University.

Who is sponsoring NCT04451967?

NCT04451967 is sponsored by Second Hospital of Jilin University.

What drugs are being tested in NCT04451967?

Interventions in NCT04451967: thrombolysis.

What condition does NCT04451967 study?

NCT04451967 studies Acute Myocardial Infarction.

Is NCT04451967 still recruiting?

NCT04451967 is currently status unknown. Last updated 30 June 2020.

Last reviewed 2020-06-30 · How we verify

NCT04451967

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute Myocardial Infarction Study in Northeastern China

Status unknown Last updated 30 June 2020

What this trial tests

trial testing thrombolysis in Acute Myocardial Infarction in 3,159 participants. Status unknown.

Timeline

9 September 2019

Primary endpoint
9 September 2020

9 September 2022

Quick facts

Lead sponsor	Second Hospital of Jilin University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	3,159
Start date	9 September 2019
Primary completion	9 September 2020
Estimated completion	9 September 2022
Sites	1 location across China

Drugs / interventions tested

thrombolysis

Conditions studied

Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →

Sponsor

Second Hospital of Jilin University

Who can join

Eligibility, any sex, with Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Protocol for the Acute Myocardial Infarction Study in Northeastern China (AMINoC): a real-world prospective cohort study.
Li T, Wu J, Liu J, Sun W, et al · · 2021 · cited 2× · PMID 34035090 · DOI 10.1136/bmjopen-2020-042936

Verify or expand the search:

Other recruiting trials for Acute Myocardial Infarction

Currently open trials in the same condition.

NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
NCT06947135 — Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury · NA · recruiting
NCT06515730 — Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction · Phase 4 · recruiting
NCT07522164 — Acute Myocardial Infarction Clinical Cohort · active not recruiting

Other Second Hospital of Jilin University trials

Trials by the same sponsor.

NCT07272655 — AAR/AAR+HAR vs AAR+TAR+FET for Type A Aortic Intramural Hematoma · NA · not yet recruiting
NCT07057713 — Total Arterial vs. Mixed Grafting in Left Coronary CABG · NA · not yet recruiting
NCT06787651 — Comparison of RIMA-SVG and Ao-SVG Techniques in Coronary Artery Bypass Grafting · NA · active not recruiting
NCT06218160 — The Addition of Hydromorphone to Local Anesthetics for the Repair of Inguinal Hernias in Elderly Patients · NA · completed
NCT06205199 — Analgesic Effect of Ropivacaine Combined With Hydromorphone for CSEA After Total Knee Arthroplasty · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04451967 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Hospital of Jilin University
Last refreshed: 30 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04451967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing